Pediatric bone marrow microenvironment before and after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study comparing donors and recipients
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06664-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Hematology, 2025. Verfasst von Pan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem cell Transplantation, Baoding Hospital of Beijing Children's Hospital, Capital Medical University, Baoding, 071000, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Bone Marrow, Tissue Donors, Stem Cell Niche. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
To compare the bone marrow microenvironment between healthy children and adults and investigate the association between the posttransplant bone marrow microenvironment and PGF in pediatric HSCT recipients. This retrospective study involved pediatric patients who underwent allogeneic-HSCT at Beijing Children's Hospital and Baoding Children's Hospital between January 2021 and June 2024. Bone marrow samples were collected before HSCT and between Days 14 and 90 post-HSCT to measure the percentages of endothelial progenitor cells (EPCs) and hematopoietic stem cells (CD34 + HSCs), as well as reactive oxygen species (ROS) levels. Selected donors were enrolled as controls, and their bone marrow samples were similarly assessed for those parameters. One hundred forty pediatric patients and 48 bone marrow donors were included in this study. Subsequent analysis revealed that adult donors had a significantly lower proportion of HSCs compared with the 0-6-year donors subgroup (0.865% (0.03, 2.21) vs. 3.38% (1.38, 5.23); U = 3.93, P 0.071% in the bone marrow at 14-90 days post-transplantation predicted GGF outcomes (AUC = 0.874; 95% CI: 0.743-1.000). These findings suggest that compared with their adult counterparts, pediatric bone marrow niches possess superior hematopoietic regenerative capacity and reduced oxidative stress and that a lower proportion of EPCs is responsible for defective hematopoiesis in PGF pediatric patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem cell Transplantation, Baoding Hospital of Beijing Children's Hospital, Capital Medical University, Baoding, 071000, China.
- National Center for Children's Health in Baoding, Baoding, 071000, China.
- Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, 100045, China.
- National Key Discipline of Pediatrics (Capital Medical University), Beijing, 100045, China.
- Laboratory of Major Diseases in Children, Ministry of Education, Beijing, 100045, China.
- Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China.
Zitieren
APA
Zhang, P., Wei, A., Zhu, G., Wang, B., Jia, C., Luo, Y., Jing, Y., Yang, W., Zhang, K., Chen, W., Qin, M., & Yang, J. (2025). Pediatric bone marrow microenvironment before and after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study comparing donors and recipients. Annals of Hematology. https://doi.org/10.1007/s00277-025-06664-9
Vancouver
Zhang P, Wei A, Zhu G, Wang B, Jia C, Luo Y, et al. Pediatric bone marrow microenvironment before and after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study comparing donors and recipients. Annals of Hematology. 2025. doi:10.1007/s00277-025-06664-9
BibTeX
@article{Zhang2025,
author = {Zhang, Pan and Wei, Ang and Zhu, Guanghua and Wang, Bin and Jia, Chenguang and Luo, Yanhui and Jing, Yuanfang and Yang, Wei and Zhang, Kaige and Chen, Wei and Qin, Maoquan and Yang, Jun},
title = {Pediatric bone marrow microenvironment before and after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study comparing donors and recipients},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06664-9}
}
EUVIMED